Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Balbi M, Donadon V, Ghersetti M, Grazioli S, Valentina GD, Gardenal R, Mas MD, Casarin P, Zanette G, Miranda C, Cimarosti P.

Int J Environ Res Public Health. 2010 Apr;7(4):1366-78. doi: 10.3390/ijerph7041366. Epub 2010 Mar 29.

2.

Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Donadon V, Balbi M, Valent F, Avogaro A.

World J Gastroenterol. 2010 Jun 28;16(24):3025-32.

3.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.

Donadon V, Balbi M, Mas MD, Casarin P, Zanette G.

Liver Int. 2010 May;30(5):750-8. doi: 10.1111/j.1478-3231.2010.02223.x. Epub 2010 Mar 12.

PMID:
20331505
4.

Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.

Donadon V, Balbi M, Zanette G.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):465-7. doi: 10.1586/egh.09.41. No abstract available.

PMID:
19817667
5.

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.

Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, Gardenal R, Dal Mas M, Casarin P, Zanette G, Miranda C.

World J Gastroenterol. 2009 May 28;15(20):2506-11.

6.

Type 2 diabetes mellitus and increased prevalence of hepatocarcinoma in HIV-infected population.

Perciaccante A, Zanette G, Donadon V.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):573. doi: 10.1097/QAI.0b013e31818d5fb6. No abstract available.

PMID:
19202464
7.

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.

Donadon V, Balbi M, Casarin P, Vario A, Alberti A.

World J Gastroenterol. 2008 Oct 7;14(37):5695-700.

8.

Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy).

Covolo L, Gelatti U, Talamini R, Garte S, Trevisi P, Franceschi S, Franceschini M, Barbone F, Tagger A, Ribero ML, Parrinello G, Donadon V, Nardi G, Donato F.

Cancer Causes Control. 2005 Sep;16(7):831-8.

PMID:
16132793
9.

N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.

Gelatti U, Covolo L, Talamini R, Tagger A, Barbone F, Martelli C, Cremaschini F, Franceschi S, Ribero ML, Garte S, Nardi G, Donadon V, Donato F.

Int J Cancer. 2005 Jun 10;115(2):301-6.

10.

Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.

Mazzaro C, Zorat F, Comar C, Nascimben F, Bianchini D, Baracetti S, Donada C, Donadon V, Pozzato G.

J Rheumatol. 2003 Aug;30(8):1775-81.

PMID:
12913934

Supplemental Content

Loading ...
Support Center